Login / Signup

Human BCL10 Deficiency due to Homozygosity for a Rare Allele.

Ana Van Den RymPrasad TaurRubén Martinez-BarricarteLazaro LorenzoAnne PuelPablo Gonzalez-NavarroAmbreen PandrowalaVijaya GowriAmin SafaVictor ToledanoCarolina Cubillos-ZapataEduardo López-CollazoMaria VelaAntonio Pérez-MartínezSilvia Sánchez-RamónMaria J RecioJean-Laurent CasanovaMukesh M DesaiRebeca Perez de Diego
Published in: Journal of clinical immunology (2020)
In 2014, a child with broad combined immunodeficiency (CID) who was homozygous for a private BCL10 allele was reported to have complete inherited human BCL10 deficiency. In the present study, we report a new BCL10 mutation in another child with CID who was homozygous for a BCL10 variant (R88X), previously reported as a rare allele in heterozygosis (minor allele frequency, 0.000003986). The mutant allele was a loss-of-expression and loss-of-function allele. As with the previously reported patient, this patient had complete BCL10 deficiency. The clinical phenotype shared features, such as respiratory infections, but differed from that of the previous patient that he did not develop significant gastroenteritis episodes or chronic colitis. Cellular and immunological phenotypes were similar to those of the previous patient. TLR4, TLR2/6, and Dectin-1 responses were found to depend on BCL10 in fibroblasts, and final maturation of T cell and B cell maturation into memory cells was affected. Autosomal-recessive BCL10 deficiency should therefore be considered in children with CID.
Keyphrases